Skip to main content
. 2020 Apr 2;40(2):105-112. doi: 10.5144/0256-4947.2020.105

Table 1.

Characteristics of patients with sellar masses in the city of Al Ain, United Arab Emirates from 2011 to 2016.

Males (n=102) Females (n=170) All patients
Age (years) 43.8 (12.8) 38.6 (14.1) 40.6 (13.8)
Native citizens 26 (25.5) 102 (60.0) 128 (46.5)
Diagnosis
 Prolactinoma 33 (32.4) 106 (62.4) 139 (51.1)
 Nonfunctioning pituitary adenoma 35 (34.3) 34 (20.0) 69 (25.4)
 Somatotroph adenoma 21 (20.6) 11 (6.5) 32 (11.8)
 Craniopharyngioma 10 (9.8) 5 (2.9) 15 (5.5)
 Corticotroph adenoma -- 5 (2.9) 5 (1.8)
 Rathkeys cleft cyst -- 4 (2.4) 4 (1.5)
 Othersa 3 (2.9) 5 (2.9) 8 (2.9)
Clinical manifestationsb
 Headache 52/82 (63.4) 46/101 (45.5) 98/183 (53.6)
 Menstrual disorders - 51/92 (55.4) 51/92 (55.4)
 Visual loss 34/82 (41.5) 6/98 (6.1) 40/180 (22.2)
 Incidental 16/80 (20) 18/100 (18) 34/180 (18.9)
 Decreased libido 14/59 (23.7) - 14/59 (23.7)
Secondary hormonal dysfunctionb
 Growth hormone deficiency 11/42 (26.2) 6/40 (15) 17/82 (20.7)
 Hypogonadism 30/54 (55.6) 15/54 (27.8) 45/108 (41.7)
 Hypothyroidism 17/65 (26.2) 7/80 (8.8) 24/145 (16.6)
 Adrenal insufficiency 15/64 (23.4) 2/81 (2.5) 17/145 (11.7)
 Diabetes Insipidus -- -- --
Mode of therapyb
Surgery 49/99 (49.5) 33/167 (19.8) 82/266 (30.8)
Radiation therapy 14/100 (14) 10/166 (6) 24/266 (9)

Data are number (%) or mean (SD).

a

Others: Meningioma (5), hypophysitis (1), arachnoid cyst (1) and pinecytoma (1)

b

Denominator is less than 272 as only those with available data were included.